Berkshire Biomedical Awarded Phase II Funding for NIH Research Grant to Support Continued Development of the COPA™ System for Automated at Home Methadone Administration
/PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or "the Company"), focused on developing its proprietary, hand-held, automated personalized drug...
United States John Timberlake National Institute On Drug Abuse Company Phase Oral Prescription Administration System Mental Health Services Administration
Source: prnewswire.com